Tenax Therapeutics, Inc.
TENX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000034956
In the last 90 days, Tenax Therapeutics, Inc. insiders filed 6 open-market purchases and 0 sales; 111 institutions reported holding it in 13F filings for Q2 2026, worth $441.4M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Tenax Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- −1 vs. Q1 2021
- Shares held
- 3.51M
- −291.2K (−7.7%) vs. Q1 2021
- Total value
- $7.32M
- +$107.0K (+1.5%) vs. Q1 2021
- New holders
- 1
- 7 more added
- Sold out
- 2
- 4 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TENX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $441.4M |
| Q1 2026 | 81 | $341.0M |
| Q4 2025 | 49 | $85.9M |
| Q3 2025 | 34 | $35.9M |
| Q2 2025 | 26 | $12.9M |
| Q1 2025 | 23 | $13.1M |
| Q4 2024 | 21 | $8.43M |
| Q3 2024 | 19 | $4.25M |
| Q2 2024 | 11 | $57.2K |
| Q1 2024 | 9 | $30.5K |
| Q4 2023 | 17 | $367.6K |
| Q3 2023 | 16 | $184.8K |
| Q2 2023 | 15 | $119.2K |
| Q1 2023 | 13 | $230.6K |
| Q4 2022 | 19 | $691.8K |
| Q3 2022 | 29 | $1.24M |
| Q2 2022 | 25 | $2.08M |
| Q1 2022 | 25 | $6.54M |
| Q4 2021 | 28 | $8.38M |
| Q3 2021 | 25 | $13.6M |
| Q2 2021 | 25 | $7.32M |
| Q1 2021 | 26 | $7.21M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Tenax Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 2,019,995 | $4.20M | 0.11% | 00.0% | Unchanged |
| BlackRock Inc. | 512,110 | $1.06M | 0.00% | −86,992−14.5% | Reduced |
| Vanguard Group Inc | 356,347 | $742.0K | 0.00% | +178,455+100.3% | Added |
| Renaissance Technologies LLC | 192,232 | $400.0K | 0.00% | −555,600−74.3% | Reduced |
| State Street Corp | 136,404 | $296.0K | 0.00% | +136,404 | New |
| Financial Advisory Service, Inc. | 58,326 | $127.0K | 0.01% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 51,895 | $113.0K | 0.00% | −8,517−14.1% | Reduced |
| Geode Capital Management, LLC | 51,212 | $111.0K | 0.00% | −1,089−2.1% | Reduced |
| Morgan Stanley | 38,650 | $80.0K | 0.00% | +38,648+1,932,400.0% | Added |
| Northern Trust Corp | 34,671 | $72.0K | 0.00% | +17,647+103.7% | Added |
| Ameriprise Financial Inc | 30,000 | $62.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 20,111 | $44.0K | 0.00% | +4,147+26.0% | Added |
| Tower Research Capital LLC (TRC) | 1,231 | $3.00K | 0.00% | +600+95.1% | Added |
| UBS Group AG | 980 | $2.00K | 0.00% | +143+17.1% | Added |
| Banque Cantonale Vaudoise | 1,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 98 | $0 | 0.00% | +2+2.1% | Added |
| Harbour Investments, Inc. | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Skandinaviska Enskilda Banken AB (publ) | 140 | $0 | 0.00% | 00.0% | Unchanged |
| Gradient Investments LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Hudock, Inc. | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Horan Securities, Inc. | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Laurel Wealth Planning LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Blair William & Co | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Valeo Financial Advisors, LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |